Long-Term Disease-Free Survival After Sorafenib-Combined Chemotherapy for Refractory Metastatic Testicular Germ Cell Tumor: A Five-Year Follow-Up
{{output}}
The management of late-stage refractory metastatic non-seminomatous germ cell tumor (NSGCT) remains a significant challenge in oncology. While first-line BEP (bleomycin, etoposide, cisplatin) chemotherapy achieves high cure rates in most patients, those who pr... ...
